Pseudomyxoma Peritonei clinical trials

The registry lists 37 studies for Pseudomyxoma Peritonei across more than 10 countries. 14 are recruiting or about to start. 22 of them are mainly about Pseudomyxoma Peritonei (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-13.

Get an email when these change. Save the Pseudomyxoma Peritonei studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Recruiting: 12
Completed: 11
Status unknown: 8
Not yet recruiting: 2
Active, not recruiting: 2
Withdrawn: 1

Phase

Phase 2: 10
Phase 1: 5
Phase 3: 2
Early Phase 1: 1

Where

United States: 16
Italy: 5
France: 4
United Kingdom: 4
Belgium: 3
Spain: 3

Who runs them

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (3) · Beijing Tsinghua Chang Gung Hospital (2) · University of Southampton (2) · Oslo University Hospital (2) · Mercy Medical Center (2) · Hospices Civils de Lyon (2) · Case Comprehensive Cancer Center (2) · Appendix Cancer Pseudomyxoma Peritonei Research Foundation (1)

What is being tested here

Drugs under test in Pseudomyxoma Peritonei studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Mitomycin	1	1	2
Capecitabine	1	0	2
Alemtuzumab	1	0	1
Tacrolimus	1	0	1
Sirolimus	1	0	1
Homo sapiens whole	1	1	1
Metformin	1	0	1
Molgramostim	1	0	1
Tislelizumab	1	0	1
Acetylcysteine	0	0	2

Drug classes tested here Antimetabolites 1 open

Coming up

2phase 3 studies under way

3studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3, phase 3 first

Jun 2027Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery · Phase 3 · CSL Behring
Dec 2026Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis · Institut du Cancer de Montpellier - Val d'Aurelle
Nov 2027Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Who these studies take

Of the 12 Pseudomyxoma Peritonei studies recruiting now, 10 (83%) set no upper age limit and 1 (8%) stop at 75 or younger. 3 (25%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (8%) take healthy volunteers.

Recruiting studies that take each age, of 12
Age	Women	Men
10	2 (17%)	2 (17%)
18	12 (100%)	12 (100%)
30	12 (100%)	12 (100%)
40	12 (100%)	12 (100%)
50	12 (100%)	12 (100%)
65	12 (100%)	12 (100%)
75	11 (92%)	11 (92%)
85	10 (83%)	10 (83%)

Across all 37 studies, recruiting or not: 11% stop at 75 or younger and 0% at 65; 24% take children; 5% are for women only and 0% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 37 of 37. search them.